tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Technical Analysis

686 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Ultragenyx Pharmaceutical’s (RARE) Moving Averages Convergence Divergence (MACD) indicator is 0.73, suggesting Ultragenyx Pharmaceutical is a Sell.
Ultragenyx Pharmaceutical’s (RARE) 20-Day exponential moving average is 42.44, while Ultragenyx Pharmaceutical’s (RARE) share price is $42.55, making it a Buy.
Ultragenyx Pharmaceutical’s (RARE) 50-Day exponential moving average is 42.22, while Ultragenyx Pharmaceutical’s (RARE) share price is $42.55, making it a Buy.

Ultragenyx Pharmaceutical (RARE) Pivot Points

Jul 22, 2024, 06:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
39.04
40.51
41.65
43.12
44.26
45.73
46.87
Fibonacci
40.51
41.51
42.13
43.12
44.12
44.74
45.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ultragenyx Pharmaceutical (RARE) Moving Averages

Jul 22, 2024, 06:42 AM
Period
Simple
Exponential
MA5
43.79Sell
43.30Sell
MA10
43.42Sell
43.11Sell
MA20
41.96Buy
42.44Buy
MA50
41.25Buy
42.22Buy
MA100
44.13Sell
42.79Sell
MA200
42.86Sell
41.80Buy
Ultragenyx Pharmaceutical’s (RARE) 10-Day exponential moving average is 43.11, while Ultragenyx Pharmaceutical’s (RARE) share price is $42.55, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) 100-Day exponential moving average is 42.79, while Ultragenyx Pharmaceutical’s (RARE) share price is $42.55, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) stock price is $42.55 and Ultragenyx Pharmaceutical’s (RARE) 50-day simple moving average is 41.25, creating a Buy signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $42.55 and Ultragenyx Pharmaceutical’s (RARE) 100-day simple moving average is 44.13, creating a Sell signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $42.55 and Ultragenyx Pharmaceutical’s (RARE) 200-day simple moving average is 42.86, creating a Sell signal.

Ultragenyx Pharmaceutical (RARE) Technical Indicators

Jul 22, 2024, 06:42 AM
Name
Value
Implied Action
RSI (14)
51.61
Neutral
STOCH (9,6)
45.21
Neutral
STOCHRSI (14)
52.30
Neutral
MACD (12,26)
0.73
Sell
ADX (14)
16.59
Buy
Williams %R
-55.68
Buy
CCI (14)
35.66
Neutral
ATR (14)
1.71
-
Ultimate Oscillator
51.95
Neutral
ROC
3.53
Buy
Ultragenyx Pharmaceutical’s (RARE) Relative Strength Index (RSI) is 51.61, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Trend Strength Indicator (ADX) is 16.59, creating a Buy signal.
Ultragenyx Pharmaceutical’s (RARE) Commodity Channel Index (CCI) is 35.66, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Price Rate of Change (ROC) is 3.53, creating a Buy signal.

FAQ

Is RARE a Buy, Hold, or Sell?
Based on RARE’s technical indicators, RARE is a Hold.
    What is RARE’s RSI (14)?
    RARE’s RSI (14) is 51.61, which suggests RARE is a Neutral.
      What is RARE’s MACD?
      RARE’s MACD is 0.73, which suggests RARE is a Sell.
        What is RARE’s 5-day moving average?
        RARE’s 5-day moving average is 43.79, which suggests RARE is a Sell.
          What is RARE’s 20-day moving average?
          RARE 20-day moving average is 41.96, which suggests RARE is a Buy.
            What is RARE’s 50-day moving average?
            RARE’s 50-day moving average is 41.25, which suggests RARE is a Buy.
              What is RARE’s 200-day moving average?
              RARE’s 200-day moving average is 42.86, which suggests RARE is a Sell.
                What is RARE’s Williams % R (14)?
                RARE’s Williams % R (14) is -55.68, which suggests RARE is a Buy.
                  What is RARE’s CCI (14)?
                  RARE’s CCI (14) is 35.66, which suggests RARE is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis